Fighting for access to Spinraza

Information Morning - Moncton

There are increasing calls to add a drug for spinal muscular atrophy patients in Canada to federal and provincial drug plans. The drug nusinersen is marketed as Spinraza. It's covered for some, but not others. Brittany Roberts of Shediac has SMA, but does not qualify for the drug. This is her story.

More From Radio/Information Morning - Moncton